Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Retained Earnings (2018 - 2026)

TransMedics has reported Retained Earnings over the past 8 years, most recently at $124000.0 for Q4 2025.

  • For Q4 2025, Retained Earnings rose 134.07% year-over-year to $124000.0; the TTM value through Dec 2025 reached $124000.0, up 134.07%, while the annual FY2025 figure was $124000.0, 134.07% up from the prior year.
  • Retained Earnings for Q4 2025 was $124000.0 at TransMedics, up from -$383.3 million in the prior quarter.
  • Over five years, Retained Earnings peaked at $124000.0 in Q4 2025 and troughed at -$507.7 million in Q3 2023.
  • A 5-year average of -$252.9 million and a median of -$395.5 million in 2025 define the central range for Retained Earnings.
  • Biggest five-year swings in Retained Earnings: tumbled 508897.75% in 2022 and later surged 134.07% in 2025.
  • Year by year, Retained Earnings stood at -$188000.0 in 2021, then decreased by 19.68% to -$225000.0 in 2022, then rose by 11.56% to -$199000.0 in 2023, then tumbled by 82.91% to -$364000.0 in 2024, then surged by 134.07% to $124000.0 in 2025.
  • Business Quant data shows Retained Earnings for TMDX at $124000.0 in Q4 2025, -$383.3 million in Q3 2025, and -$407.7 million in Q2 2025.